Siemens Healthineers


04/11/19 -"We have made some first adjustments to our expectations as we still see 2020 as a kind of transition year. Despite some strong and profitable contributions from Imaging, we have incorporated Advanced ..."

Pages
71
Language
English
Published on
04/11/19
You may also be interested by these reports :
23/04/24
We have factored the 2023 actual figures into our model ahead of the availability of the annual report and more detailed information. The difference ...

22/04/24
Sartorius Stedim reported softer-than-expected Q1 24 numbers, missing the consensus by 5.7%/3.4% on the top line/bottom line, respectively. The ...

22/04/24
Sartorius reported softer-than-expected Q1 24 numbers, missing the consensus by 5.4% on the top line, but beating (+2.4%) on the bottom line. The ...

19/04/24
EssilorLuxottica’s Q1 sales performance was slightly ahead of the market’s expectations. Group revenue grew by 5.5% yoy (+65bp vs the consensus), led ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO